KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medtronic (MDT) EPS (Weighted Average and Diluted) (2016 - 2026)

Medtronic's EPS (Weighted Average and Diluted) history spans 13 years, with the latest figure at $0.89 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 11.88% to $0.89 in Q1 2026 year-over-year; TTM through Jan 2026 was $3.59, a 9.12% increase, with the full-year FY2025 number at $3.61, up 30.8% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.89 in Q1 2026 for Medtronic, down from $1.07 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for MDT hit a ceiling of $1.1 in Q1 2022 and a floor of $0.32 in Q4 2022.
  • Historically, EPS (Weighted Average and Diluted) has averaged $0.83 across 5 years, with a median of $0.88 in 2023.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 67.01% in 2022 and later surged 112.5% in 2023.
  • Tracing MDT's EPS (Weighted Average and Diluted) over 5 years: stood at $0.32 in 2022, then surged by 112.5% to $0.68 in 2023, then soared by 45.59% to $0.99 in 2024, then rose by 8.08% to $1.07 in 2025, then dropped by 16.82% to $0.89 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for MDT at $0.89 in Q1 2026, $1.07 in Q4 2025, and $0.81 in Q3 2025.